| 
      
        | Patient ID | ART regimen Started | Months | Viral Load | NRTI Resistance    Mutations affecting susceptibility | NNRTI Resistance Mutations    affecting susceptibility |  
        | 206 | ZDV+3TC+NVP | 36 | 1.24E+05 | V75M, V118I, M184V,    L210W, T215Y | K101E, Y181C, G190A |  
        | 208 | D4T30+3TC+NVP | 36 | 6.78E+04 | V118I, M184V, L210W,    T215Y | A98G, K101A, G190A |  
        | 210 | D4T+3TC+NVP | 46 | 6.20E+04 | F116Y, Q151M, M184V,    L210W, T215Y | K103N |  
        | 211 | ZDV+3TC+EFV | 35 | 9.47E+04 | M184V, T215Y | K103N, Y181C, H221Y |  
        | 214 | D4T+3TC+NVP | 25 | 4.82E+05 | L74V, M184V, T215Y | A98G, K101E, Y181C,    G190A |  
        | 217 | D4T+3TC+NVP | 45 | 8.61E+05 |  | V90I, Y181C, G190A |  
        | 218 | D4T+3TC+NVP | 42 | 1.92E+05 | V118I, M184V, L210S,    T215Y | A98G, K101E, G190A |  
        | 221 | D4T30+3TC+NVP | 29 | 4.01E+04 | M184V, K219Q | G190A |  
        | 222 | ZDV+3TC+NVP | 51 | 4.55E+05 | M184V, L210W, T215Y | V106A |  
        | 223 | D4T+3TC+NVP | 41 | 1.83E+06 | L74I, M184V, T215F | V90I, K103N, V108I,    V179F, Y181C, H221Y |  
        | 228 | ZDV+3TC+EFV | 82 | 1.74E+04 | M184V | A98G, K103N |  
        | 229 | D4T+3TC+NVP | 42 | 2.46E+05 | V75M, V118I, M184V,    L210W, T215Y | A98G, K101E, G190A |  
        | 230 | D4T+3TC+NVP | 45 | 1.79E+04 | M184V, T215Y | K103N, E138Q |  |